Home / Markets / Reporting Wrap: CSL, Redbubble & Magellan

Reporting Wrap: CSL, Redbubble & Magellan

Earnings season is in full swing, with companies providing results from FY22 and outlooks for the year ahead. Here we summarise recent results of three popular ASX shares.
Markets

CSL is ready to rebound

CSL’s profit fell for the first since 2016 as the business suffered for a second year from constrained plasma collections.

The pandemic has pressed the brakes on plasma supply, as blood centres were closed or donors were reluctant to venture unnecessarily outside the home. Government stimulus also meant lower-socio-economic donors opted to skip donations.

  • Net profit decreased 6 per cent to US$2.26 billion in FY22 while the total full-year dividend remained steady at US$2.22 (AU$3.17).

    CSL Seqirus, which houses influenza vaccine treatments, saw an uptick in demand as a heightened awareness of viruses led to a greater desire for preventative medicines. Subsequently, gross profit increased 16 per cent to US$1.15 billion.

    However, this wasn’t enough to offset the decline in CSL Behring. The division actually increased plasma collections by 24 per cent, but this came at an increased cost and treatment lead-times mean it takes months for new supply to flow through. As a result, gross profit from blood and other rare diseases fell 4 per cent to US$4.58 billion.

    CSL is forecasting a return to growth in FY23, guiding for net profit from US$2.4 to US$2.5 billion. This excludes earnings or costs from the recent acquisition of Vifor.

    The headwinds it faced over the past two years will soon become tailwinds, as patients return to clinicians and the rising cost of living encourages increased donations.

    Redbubble bursts

    Shares in online retailer Redbubble plunged 37 per cent in one trading day after the business extended its medium-term financial targets by three years.

    Redbubble had previously announced it would reach sufficient scale via $1.25 billion in revenue and operating margins of 13-18 per cent by 2024. This has now been pushed out to FY26-FY27 heightening investors’ fears it may not be able to reach its lofty growth ambitions.

    Exacerbating the share price decline was a swing from a $31.2 million profit in FY21 to a $24.6 million loss in FY22 as it invested in growing headcount and expanding its platform.

    The company recorded a 13 per cent decrease in marketplace revenue to $248.6 million. The rising cost of goods from logistics and fabrics inflation led to a 39.6 per cent drop in gross profit to $183.1 million.

    Redbubble noted it passed through a 6 per cent base price rise during May to offset some of the pressure. However, the biggest concern facing the business is the decline in active members, which fell 7 per cent compared to last year.

    Redbubble has clearly lost the market’s confidence and will need to return to meaningful growth in FY23 if it expects investors to back its medium-term strategy.

    Further pain ahead for Magellan

    Embattled fund manager Magellan delivered a 44 per cent profit increase to $383.0 million. However, was largely due to a one-off $148 million tax expense in the prior year which hid a deterioration in the underlying business.

    Earnings before tax from the core funds management business fell 11 per cent to $470.6 million, with client outflows and sub-par investment performance impacting fees.

    Magellan declared a final dividend of 68.9 cents per share, a 32.8 per cent decline on the prior year. Total distributions for the year declined 15 per cent to $1.79.

    It’s been a turbulent year for the business, which had its CEO and CIO exit the business in addition to its biggest client redeeming a $23 billion investment mandate. Magellan has come under increasing scrutiny after investment returns in the flagship Global Equity strategy began to trail its benchmark over increasing time periods.

    Subsequently, funds under management have fallen from $133.9 billion to $60.2 billion. The full effect of redemptions won’t be felt until FY23 given the majority of redemptions occurred in the second half of the year.

    Lachlan Buur-Jensen

    Lachlan is an experienced journalist writing across The Inside Investor and The Inside Adviser.




    Print Article

    Related
    What to do about the ‘concentration conundrum’: Pzena

    Owning the largest stocks has historically been a recipe for underperformance over every period, according to value house Pzena, but the madness of benchmark construction means some investors have few choices but to.

    Staff Writer | 24th Apr 2024 | More
    Small caps come into focus as concentration risk pervades major markets

    The historic outperformance of big tech stocks in the US may look like a global outlier, but many developed markets (including ours) have high levels of concentration risk. That may not be the case for long, with a likely softening interest rate environment set to re-order indexes around the world.

    Staff Writer | 22nd Apr 2024 | More
    The answer to the Magnificent Seven’s ‘really difficult investment problem’

    A huge benefit has already been realised in the price of the Magnificent Seven and it might be time to take some risk off the table instead of speculating on future fundamentals, according to Lazard.

    Staff Writer | 18th Apr 2024 | More
    Popular
  • Popular posts: